UNII 2S7830E561

CROSPOVIDONE, UNSPECIFIED

Unique Ingredient Identifier 2S7830E561 is listed as a unspecified ingredient
Unii2S7830E561
Preferred Substance NameCROSPOVIDONE
Rn9003-39-8
NcitC80893
Rxcui1310706
Inn Id4559
Unii TypeUNSPECIFIED INGREDIENT
RN9003-39-8
NCITC80893
RXCUI1310706
INN ID4559

Alternate Names

Dosage Forms

UNII 2S7830E561 CROSPOVIDONE, UNSPECIFIED is commonly included in medications in the following forms.

RouteDosage FormPotency
IMPLANTATIONPELLET2 MG
INTRA-ARTICULARINJECTION0.02 %
INTRAMUSCULARINJECTION0.02 %
INTRAUTERINESOLUTION NA
ORALCAPSULE85 MG
ORALCAPSULE (IMMED./COMP. RELEASE), HARD GELATIN15.91 MG
ORALCAPSULE, COATED, SOFT GELATIN14 MG
ORALCAPSULE, DELAYED ACTION5 MG
ORALCAPSULE, DELAYED ACTION, ENTERIC COATED NA
ORALCAPSULE, DELAYED RELEASE13.5 MG
ORALCAPSULE, ENTERIC COATED PELLETS40.5 MG
ORALCAPSULE, EXTENDED RELEASE1 MG
ORALCAPSULE, HARD GELATIN70 MG
ORALCAPSULE, SUSTAINED ACTION10.71 MG
ORALDISPERSIBLE TABLET340 MG
ORALGRANULE, FOR ORAL SUSPENSION75 MG
ORALPELLET75 MG
ORALPOWDER, FOR SUSPENSION50 MG/1SCP
ORALSUSPENSION2.5 MG/5ML
ORALSUSPENSION, SUSTAINED ACTION186.8 MG/1PKT
ORALTABLET365 MG
ORALTABLET (IMMED./COMP. RELEASE), COATED14 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED110 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL9.6 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE100 MG
ORALTABLET, CHEWABLE60 MG
ORALTABLET, COATED104 MG
ORALTABLET, CONTROLLED RELEASE NA
ORALTABLET, DELAYED ACTION84 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED50 MG
ORALTABLET, DELAYED RELEASE45 MG
ORALTABLET, DISPERSIBLE10 MG
ORALTABLET, ENTERIC COATED PARTICLES130 MG
ORALTABLET, EXTENDED RELEASE48.2 MG
ORALTABLET, FILM COATED196.7 MG
ORALTABLET, FILM COATED, EXTENDED RELEASE12 MG
ORALTABLET, FOR SUSPENSION125 MG
ORALTABLET, MULTILAYER, EXTENDED RELEASE5 MG
ORALTABLET, ORALLY DISINTEGRATING280 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE15 MG
ORALTABLET, REPEAT ACTION10 MG
ORALTABLET, SUSTAINED ACTION144 MG
ORALTABLET, SUSTAINED ACTION, COATED15.4 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED5 MG
SUBLINGUALTABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL16 MG
TOPICALEMULSION1 %W/W
TOPICALLOTION NA
TRANSDERMALFILM3.63 MG
TRANSDERMALFILM, CONTROLLED RELEASE60 MG
TRANSDERMALFILM, EXTENDED RELEASE47.5 MG
TRANSDERMALPATCH, ELECTRICALLY CONTROLLED62 MG
VAGINALSUPPOSITORY116.1 MG
VAGINALTABLET50 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.